The HIV/HCV-Coinfected Patient and New Treatment Options

被引：6

作者：

Vachon, Marie-Louise C. ^{[1
,2
]}

Dieterich, Douglas T. ^{[1
]}

机构：

[1] Mt Sinai Sch Med, Div Liver Dis, New York, NY 10029 USA

[2] Mt Sinai Sch Med, Div Infect Dis, New York, NY 10029 USA

来源：

CLINICS IN LIVER DISEASE | 2011年 / 15卷 / 03期

关键词：

HIV; Hepatitis C; Coinfection; Treatment; Direct-acting antivirals; CHRONIC HEPATITIS-C; INTERFERON PLUS RIBAVIRIN; SUSTAINED VIROLOGICAL RESPONSE; HIV-INFECTED PATIENTS; HUMAN-IMMUNODEFICIENCY-VIRUS; INSULIN-RESISTANCE; LIVER FIBROSIS; PEGYLATED INTERFERON-ALPHA-2B; ANTIRETROVIRAL THERAPY; PROTEASE INHIBITORS;

D O I：

10.1016/j.cld.2011.05.006

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Hepatitis C (HCV) treatment is on the cusp of change with the approval of the first direct-acting antivirals: telaprevir and boceprevir. Drug-drug interactions with HIV antiretrovirals, increased toxicity, and rapid selection of HCV-resistant mutants are among the treatment complexities expected in this difficult-to-treat population. Until the current standard of care changes, focus should be on strategies to optimize management of HIV/HCV-coinfected patients with currently available options. This article reviews the latest predictive factors of response to HCV treatment with the current standard of care in HIV-coinfected patients, and new treatment options.

引用

页码：585 / +

页数：14

共 50 条

[1] Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient
Rodriguez-Torres, Maribel
[J]. EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (10) : 1117 - 1128
[2] Antiviral therapy in the HCV-coinfected patient with HIV and/or HBV
James S. Park
Neeraj Saraf
Douglas T. Dieterich
[J]. Current Hepatitis Reports, 2005, 4 (2) : 68 - 74
[3] Pharmacogenetics and the treatment of HIV-/HCV-coinfected patients
Frias, Mario
Rivero-Juarez, Antonio
Lopez-Lopez, Pedro
Rivero, Antonio
[J]. PHARMACOGENOMICS, 2018, 19 (12) : 979 - 995
[4] The symptom experience of HIV/HCV-Coinfected adults
Bova, Carol
Jaffarian, Carol
Himlan, Pauline
Mangini, Linda
Ogawa, Lisa
[J]. JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2008, 19 (03): : 170 - 180
[5] Therapeutic issues in HIV/HCV-coinfected patients
Sulkowski, M. S.
Benhamou, Y.
[J]. JOURNAL OF VIRAL HEPATITIS, 2007, 14 (06) : 371 - 386
[6] Barriers to treatment of hepatitis C in HIV/HCV-coinfected adults with alcohol problems
Nunes, David
Saitz, Richard
Libman, Howard
Cheng, Debbie M.
Vidaver, John
Samet, Jeffrey H.
[J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2006, 30 (09) : 1520 - 1526
[7] Noninvasive markers of fibrosis in HIV/HCV-coinfected population
Wolff, Fernando H.
Kreitchmann, Regis
Fuchs, Sandra C.
[J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2006, 43 (02) : 249 - 249
[8] Hepatitis C virus (HCV) treatment uptake and changes in the prevalence of HCV genotypes in HIV/HCV-coinfected patients
Medrano, J.
Resino, S.
Vispo, E.
Madejon, A.
Labarga, P.
Tuma, P.
Martin-Carbonero, L.
Barreiro, P.
Rodriguez-Novoa, S.
Jimenez-Nacher, I.
Soriano, V.
[J]. JOURNAL OF VIRAL HEPATITIS, 2011, 18 (05) : 325 - 330
[9] Nevirapine pharmacokinetics in HIV-infected and HIV/HCV-coinfected individuals
Vogel, Martin
Bertram, Norbert
Wasmuth, Jan-Christian
Wyen, Christoph
Voigt, Esther
Schwarze-Zander, Carolynne
Sudhop, Thomas
Faetkenheuer, Gerd
Rockstroh, Juergen K.
Reichel, Christoph
[J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2009, 63 (05) : 988 - 991
[10] Effect of mono/dual antiretroviral therapy on suppression of HCV and HIV during treatment of HCV infection in HIV/HCV-coinfected patients
Martin-Carbonero, Luz
Dominguez-Dominguez, Lourdes
Bailon, Lucia
Torres, Rafael
Rubio, Rafael
Ron, Raquel
Moreno, Francisco
Rico, Mikel
Jimenez-Nacher, Inmaculada
Gonzalez-Garcia, Juan
Pulido, Federico
Luisa Montes, Maria
[J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2019, 37 (06): : 367 - 372

← 1 2 3 4 5 →